• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. STEALTH 360 ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS, INC. STEALTH 360 ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE, Back to Search Results
Model Number PRD-MAX-200
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Vascular Dissection (3160); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 11/10/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).The device history record for this oad lot number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.The results of the investigation are inconclusive since the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.Csi id: (b)(4).
 
Event or Problem Description
Intravascular ultrasound (ivus) of the vessels revealed mixed morphology plaque.Atherectomy was performed in the left common femoral artery (cfa), superficial femoral artery (sfa) and popliteal artery using a diamondback 360 peripheral orbital atherectomy device (oad).Access was gained in the cfa with a 6fr catheter.Two 20 second treatments were performed on low speed, followed by two 20 second treatments on medium speed in the popliteal artery with 30 second breaks between treatments.Vasodilators were administered following each treatment.Ivus was performed and revealed a spiral, flow limiting dissection from the cfa to the mid sfa.Balloon angioplasty was performed.A stent was deployed and covered the dissection.Ivus was performed and revealed the dissection to have resolved.Following the procedure, the patient was in stable condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STEALTH 360 ORBITAL ATHERECTOMY SYSTEM
Common Device Name
PERIPHERAL ATHERECTOMY DEVICE,
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS, INC.
1225 old hwy 8 nw
st. paul MN 55112
Manufacturer (Section G)
CARDIOVASCULAR SYSTEMS, INC.
1225 old hwy 8 nw
st. paul MN 55112
Manufacturer Contact
kim mcclure
1225 old hwy 8 nw
st. paul, MN 55112
6519006741
MDR Report Key15931680
Report Number3004742232-2022-00272
Device Sequence Number15089200
Product Code MCW
UDI-Device Identifier10850026568711
UDI-Public(01)10850026568711(17)240831(10)446433-1
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K190634
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 12/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/31/2024
Device Model NumberPRD-MAX-200
Device Catalogue Number7-10059-46
Device Lot Number446433-1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/10/2022
Initial Report FDA Received Date12/07/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/10/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age56 YR
Patient SexMale
Patient Weight95 KG
Patient RaceWhite
-
-